US2003176403A1PendingUtilityA1
Combination chemotherapy
Est. expiryAug 29, 2017(expired)· nominal 20-yr term from priority
A61P 35/00A61K 31/59A61P 43/00A61K 45/06A61K 31/337A61K 31/573A61K 31/675A61K 33/243
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides a method of treating a patient with vitamin-D or a derivative thereof involving the adjunctive administration of zoledronate.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . In an improved method for treating a patient by administering vitamin D or a derivaitive thereof to the patients the improvement comprising adjunctively administering zolecdroniate to the patient.
2 . The method of claim 1 , wherein the zoledronate is administered prior to administration of the vitamin D or derivative.
3 . The method of claim 1 , wherein the zoledronate is administered at a dosage between about 5 μm/kg body weight of the patient and about 25 μg/kg body weight of the patient.
4 . The method of claim 1 , wherein the vitamin D derivative is a nonhypercalcemic analog.
5 . The method of claim 1 , wherein the vitamin D derivative is 1,25D 3 .Join the waitlist — get patent alerts
Track US2003176403A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.